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Why was the cohort set up?
The Cambridge Baby Growth Study (CBGS) is a prospect-
ive, observational pregnancy and birth cohort with detailed
assessments and sample collections in infancy and continu-
ing childhood follow-up. Women were recruited during
early pregnancy from April 2001 to March 2009; they at-
tended several study visits throughout pregnancy, and then
repeatedly with their infants until the age of 2 years. The
main aim of the study has been to investigate the antenatal
and postnatal determinants of infancy growth and repro-
ductive development, including environmental, genetic, hor-
monal and nutritional exposures. Collection of extensive
anthropometric, nutritional, demographic and biological
data has allowed detailed examination of the first 1000
days of life, a time of emerging importance for the early ori-
gins of health and disease, where in utero exposures, early
growth, nutrition and genetic interactions are thought to
contribute to later-life disease risk,1–3
All women were recruited from a single study site: the
Rosie Maternity Hospital, Cambridge, UK, and the
Cambridge local research ethics committee approved the
study. Initial funding was from the European Union
Framework V, with the specific objective to investigate
the effect of environmental factors during pregnancy on
male offspring reproductive development over the first 2
years of life. From the outset, the study was designed to
also include female offspring and to collect data on in-
fancy growth and body composition. Subsequent funding
and collaborations have allowed further nested case con-
trol studies and continuing follow-up through childhood.
Cohort funding has been received from the World Cancer
Research Fund International, the Newlife Foundation for
Disabled Children, the Mothercare Group Foundation
and a collaborative research grant from the European
Society for Paediatric Endocrinology. Support from the
Medical Research Council (MRC) has been awarded
through a clinical research training fellowship
(G1001995), a Cambridge University MRC Centenary
award, and assisted by MRC Department of
Epidemiology programmatic funding (U106179472).
Lipidomic assays were also supported by the MRC
(UD99999906) and the Cambridge Lipidomics Biomarker
Research Initiative (G0800783). Genotyping and placen-
tal RNA work was funded by grants from the Evelyn
Trust, the Wellbeing of Women and Diabetes UK (11/
0004241). Funding from Mead Johnson Nutrition has
allowed further biochemical analysis of biological speci-
mens, in particular breast milk samples, and childhood
follow-up. Continued support and funding are provided
by the National Institute of Human Research Cambridge
Comprehensive Biomedical Research Centre.
Who is in the cohort?
Women were recruited during early pregnancy, at ap-
proximately 12 weeks of gestation, at their first routine
antenatal ultrasound clinic in the Rosie Maternity
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Hospital, Cambridge, UK. At the time, the hospital had
approximately 5000 deliveries per year from a mixed
urban and rural community mainly residing in South
Cambridgeshire. Research nurses introduced details of
the study and distributed information sheets. Those who
showed interest in the study were followed up by tele-
phone and the first study visit was arranged, where in-
formed written consent was provided. Exclusion criteria
included women under the age of 16 years, or those un-
able to give informed consent.
Figure 1 shows the numbers of participants accrued and
followed up throughout the study period: 2229 women
were recruited in early pregnancy ( 50% of those who
were approached for participation) and 1658 offspring
were studied (including 22 sets of twins), following add-
itional written consent from the mother on behalf of her in-
fant(s). Of these infants, 1183 were seen at 1 year of life
and 1061 completed the infancy study protocol at age 2
years.
Offspring who were followed until at least 1 year of
age, and are now aged between 5 and 10 years, are cur-
rently being invited for a follow-up study visit. At the time
of writing, 423 children have been invited out of a total of
917 eligible children, with a 44% participation rate.
Table 1 describes the characteristics of the CBGS co-
hort. Demographic data were not available for non-partici-
pating women. However, the recruited term and late
preterm (gestational age >¼ 36 weeks) mother-infant
dyads were similar to the overall population of births at
the Rosie Maternity Hospital, as shown in Table 2, albeit
CBGS mothers were slightly older and more likely to be
primiparous.
How often have they been followed?
The study protocol included visits across antenatal, peri-
natal and postnatal periods, with a wide range of data col-
lection (Table 3).
Pregnancy Visits
Antenatally, women were seen during each trimester of
pregnancy. This included an early pregnancy maternal
venous blood sample at approximately12 weeks of gesta-
tion for biochemical analytes and DNA extraction, a 75-g
oral glucose tolerance test (OGTT) at 28 weeks and admin-
istration of a questionnaire on parental demographics and
environmental exposures, including diet and chemical
exposure, which was returned in late pregnancy.
Birth visit
Cord blood and placental samples were collected at birth
where possible. Birthweight was recorded at delivery by
midwives and obtained from the hospital notes. Infants
were also examined as newborns, as early as possible in the
first 2 weeks of life, either in hospital or at home visits,
with further anthropometric measurements as detailed
below. Infant DNA was extracted from the cord blood
sample, where available.
Infancy visits
Infants were seen at research clinic visits at 3, 12, 18 and 24
months of age. These visits included detailed longitudinal
anthropometric measurements and questionnaires on feed-
ing, behaviour and illness. Biological samples consisted of
repeated dried blood spot collection, breast milk samples
Figure 1. Participant numbers from recruitment and the infancy study protocol. Singlets, singletons.










and infant venous or mouth swab samples for DNA when
cord blood was not available. A mouth swab was also
obtained from the father. Clinics were held in two locations
due to the large geographical catchment area of the Rosie
Maternity Hospital: at the Cambridge Biomedical Campus
(the NIHR-Wellcome Trust Clinical Research Facility or the
MRC Epidemiology Clinical Research Facility) and at the
Princess of Wales Hospital, Ely.
Mothers and infants who completed the initial follow-
up to 2 years of age were very similar to those lost to fol-
low-up, although they were slightly older and more likely
to be of Caucasian ethnicity (Table 4).
Table 1. Cohort characteristics (N indicates the total sample with available data)
Continuous variables N Mean (SD) Categorical variables N % (with outcome
specified)
Parental Ethnicity 1619
Maternal age (years) 1338 33.5 (4.3) White Caucasian 95.3
Paternal age (years) 1291 35.7 (5.4) Black 1.3
Maternal height (cm) 1237 165.9 (7.2) Asian 1.7
Maternal pre-pregnancy weight (kg) 1203 66.3 (12.4) Other 1.7
Maternal pre-pregnancy BMI (kg/m2) 1173 24.1 (4.6)
Maternal pregnancy weight gain (kg) 866 8.2 (6.7) Maternal education 780
Index of multiple deprivation 920 8.9 (4.2) University degree-level 62.7
Other 37.3




Primiparous pregnancy 1629 43.4
Recorded diabetic pregnancy 1562 7
Birth
Gestational age 1638 39.8 (1.6)
Birthweight (kg) 1657 3.47 (0.55) Small for gestational age 1657 1.1
Newborn length (cm) 1599 51.4 (2.6) Large for gestational age 1657 2.7
Newborn head circumference (cm) 1602 35.3 (1.7)
Newborn mean skinfold thickness (mm) 1599 6.3 (1.6) Delivery (caesarian delivery) 1630 30.2
Infant sex (male) 1660 51.7
Infancy
3-month weight (kg) 1340 6.15 (0.83) Rapid infancy weight gain 0–12 months 1179
3-month length (cm) 1335 61.1 (2.6) Catch-up weight gain 26
3-month head circumference (cm) 1342 40.7 (1.4) Normal weight gain 46.7
3-month mean skinfold thickness (mm) 1342 10.8 (2.0) Catch-down weight gain 27.3
12-month weight (kg) 1182 9.97 (1.19)
12-month length (cm) 1175 75.9 (2.9)
12-month head circumference (cm) 1179 46.4 (1.4)
12-month mean skinfold thickness (mm) 1178 11.3 (2.1)
18-month weight (kg) 1094 11.36 (1.32)
18-month length (cm) 1096 82.2 (3.2)
18-month head circumference (cm) 1088 47.8 (1.5)
18-month mean skinfold thickness (mm) 1096 10.8 (2.1)
24-month weight (kg) 1051 12.61 (1.47)
24-month length (cm) 1043 87.8 (3.4)
24-month head circumference (cm) 1051 48.7 (1.5)
24-month mean skinfold thickness (mm) 1057 10.3 (2.2)
Infancy nutrition
Age stopped breastfeeding (months) 436 5.3 (3.1) 3-month feeding 1319















A Pre-school Activities Inventory (PSAI) questionnaire was
posted to a subgroup of 194 mothers of 3–4-year-old chil-
dren in 2010–11 (with 80% response rate). Children aged
5–10 years are currently being re-recruited into a follow-
up phase.
Throughout the study period, families have been kept
informed of study updates and activities, with biannual
posted or e-mailed newsletters, and through two study
events for participating families in March 2010 and May
2011.
What has been measured?
Anthropometry
A team of four trained paediatric research nurses carried
out all the measurements. Infancy anthropometry included
weight and length, and skinfold thickness measurements at
four sites (triceps, subscapular, flank, quadriceps). In
September 2006, abdominal ultrasound assessment of vis-
ceral and subcutaneous-abdominal fat depths was intro-
duced into the protocol (N¼ 498 at 3 months; N¼ 582 at
12 months, N¼ 550 at 24 months), as well as waist
Table 2. The Cambridge Baby Growth Study cohort com-
pared with all infants born at term (gestational age 36
weeks) at the Rosie Maternity Hospital in 2005 (midway
through the study).Mean (SD) or % are shown
CBGS Rosie Maternity Hospital
N¼1585 N¼4670
Birthweight (kg) 3.52 (0.49) 3.47 (0.49)
Gestational age (weeks) 40.0 (1.3) 40.0 (1.3)
Maternal age 33.5 (4.3) 30.7 (5.6)
Caucasian ethnicity 95% 91%
Spontaneous vaginal delivery 60% 60%
Primiparous 43% 22%
Index of multiple deprivation 9.0 11.5 (Cambridgeshire)
Table 3. Study schedule
Pregnancy (weeks) Infancy (months) Childhood (years) Father
12 28 36 Birth 6 weeks 3 12 18 24 3–4 5–10
Physical measures
Anthropometry      
Anogenital distance     
Abdominal ultrasound    
DXA scan 
Pubertal assessment 




Cord blood and placenta 
Dried blood spot    
Breast milk 





3-day food diary  
Pre-school activities inventory 
Table 4. Mother-infant dyads who completed infancy assess-
ments to age 2 years (N¼ 1061) compared with those infants
lost to follow-up (N¼597)
Followed-up Lost to follow-up
Mean (SD) Mean (SD)
Birthweight (kg) 3.50 (0.54) 3.44 (0.55)
Gestational age (weeks) 39.8 (1.6) 39.7 (1.7)
Maternal age (years) 33.7 (4.3) 32.8 (4.6)
Caucasian ethnicity 97% 92%
Spontaneous vaginal delivery 58% 60%
Primiparous 43% 43%
Index of multiple deprivation 8.9 (3.6) 9.0 (2.2)
Exclusively breastfed at 3 months 43% 40%










circumference measurement. This novel ultrasound
method was validated in infants against magnetic reso-
nance imaging (MRI).4 All anthropometric measures are
currently being repeated at the childhood follow-up visit,
with the addition of dual-energy X-ray absorptiometry
(DXA) scans.
Anogenital distance (AGD) was measured using a modi-
fied version of a previously published method,5 defined as
the distance from the centre of the anus to:the junction of
smooth perineal skin and rugated skin of the scrotum in
boys; and the lower vaginal opening in girls, as well as pen-
ile length in boys, using Vernier calipers.Measurement of
AGD was added to the CBGS protocol in 2006.
For all physical measurements, there were regular train-
ing and quality control sessions and the technical error of
measurements (TEM) within and between observors was
calculated. Over the study period, the relative intraob-
server TEM ranged as follows: for infant length, between
0.03 and 0.50%; for individual skinfold thickness meas-
urements, between 0.4 and 2.8%; for intra-abdominal
depth, between 0.3 and 1.7%; and for subcutaneous
abdominal fat depth, between 1.1 and 2.6%. Relative
interobserver TEM were: for infant length, 0.7%; for indi-
vidual skinfold thickness measurements, 2.0 to 3.2%; for
intra-abdominal depth, 3.2%; and for subscutaneous
abdominal fat depth, 3.6%. Interobserver TEM for AGD
was 9.6% for males and 5.7% for females.
Biological specimens
During pregnancy, a non-fasting venous blood sample was
collected from mothers at approximately 12 weeks of ges-
tation, into endocrine disrupting chemicals (EDC) contam-
ination-free glass containers. EDCs, including phthalate
metabolites and phenols of mothers with singleton male
pregnancies have been measured using liquid chromatogra-
phy tandem mass spectrometry. A fasting 75 g-OGTT was
completed at 28 weeks of gestation in 1071 women. Cord
blood and placental tissue were collected when possible.
RNA was extracted from placental tissues (N¼ 420).
Genomic DNA was extracted from cord blood samples,
maternal and/or infancy blood samples or mouth swabs,
and paternal mouth swabs for single nucleotide
polymorphism(SNP) genotyping. A total of 845 trios have
been extracted and used in analyses.
Dried blood spot samples (DBS) were collected repeat-
edly between 3 to 24 months of age. Capillary heel-prick
blood sampling was used, and single drops of blood were
added to untreated filter paper (Ahlstrom 226, ID
Biological Systems), and stored at 20C. For analysis,
3.2-mm single spots were punched from the larger DBS.
Since DBS have not been widely used, work was done to
investigate effects of storage conditions and time,6,7 and to
validate assays converted from plasma assays—for exam-
ple IGF-1, other hormones, metabolites and lipidomic
profiles.7,8
Mothers who breastfed their infants were asked to
hand-express a pooled hindmilk samplebetween 4 and 8
weeks postnatally. After feeding their infant, theyexpressed
from the same breast as they had last fed their infant from,
and repeated this process several times, so that a total of
100 mls of hindmilk was collected over a 2-week period, in
order to reduce within-day and day-to-day variations. A
total of 641 pooled breast milk samples were collected and
stored at 20C, until processed at a single time point.
Questionnaires
Several questionnaires were administered. The perinatal
questionnaire, completed in late pregnancy, included ques-
tions on socio-demographic status, self-reported maternal
(pre-pregnancy) and paternal anthropometry, medication-
s,environmental exposures and dietary and medical infor-
mation. At 3 months of infancy age, the postnatal
questionnaire included questions on infant feeding practice
(exclusive breastfeeding, mixed feeding or exclusive for-
mula feeding), health and illnesses. The revised infant
behaviour questionnaire was used to assess three main
dimensions of infant temperament.9
At the 12-month and 24-month clinic visits, a 3-day
diet diary was collected. Dietary data, measured using
household measures (teaspoon, cup etc.), age-appropriate
portion sizes and home-made food recipes, were then
coded by trained dietary assessment assistants using the
Human Nutrition Research (HNR) in-house programme
DINO (Diet in Nutrients Out), based on McCance and
Widdowson The Composition of Foods, 6th edition.10 The
DINO output generated a food code and weight for each
food item recorded. From this information, total energy
intake was calculated, as well as dietary intake of fat, satu-
rated fat, protein, carbohydrate and specific
micronutrients.
What has been found? Key findings and
publications
Findings from CBGS to date have mainly focused on the
antenatal and early postnatal determinants of infancy body
size, male genital development and exposures influencing
maternal metabolism. We have shown that DBS are a use-
ful biological medium and many serum assays can be
adapted, allowing measurement of early -ife circulating
hormones, metabolites and lipids. Our findings have there-
fore expanded current knowledge around infancy growth










and physiology, related to both prenatal and early postna-
tal exposures, in particular those of nutrition. Work with
DBS assays has begun to fill a gap in the literature with
respect to infancy hormones and metabolites, from studies
on cord blood to those in childhood. Additionally, further
knowledge of maternal and infancy metabolism may allow
biomarkers for fetal and infancy growth. Our main find-
ings from the cohort are summarized below.
Antenatal determinants of infancy size and
maternal metabolism
It is clear that antenatal determinants of infant size include
environmental in utero exposures and genetic influences,
but also their interactions. We have shown that maternal
fasting glucose levels and maternal pre-pregnancy BMI are
both independently positively related to offspring adiposity
in the non-diabetic population.11 Whereasaternal glycae-
mia was correlated with infant adiposity at birth, but not
afterwards, maternal pre-pregnancy BMI showed increas-
ingly strong associations with offspring adiposity as infants
aged.
Fetal imprinted genes
We demonstrated that fetal SNP genotypes at the pater-
nally-imprinted (maternally-expressed) gene H19 were
associated with offspring size at birth.12 Fetal genotypes at
paternally-expressed imprinted genes were also found to
influence birthweight, likely indirectly by affecting mater-
nal metabolism. Fetal genotypes at the paternally-
expressed gene IGF2 (encoding insulin-like growth factor-
2) were associated with maternal glucose levels during
pregnancy,13 and preliminary work in the CBGS has also
suggested that polymorphic variation in various pater-
nally-expressed fetal imprinted genes may also affect
maternal blood pressure.14
Infancy nutrition
Metabolic markers of infancy nutrition
Three-month insulin-like growth factor 1 (IGF-1) levels
were analysed in 566 DBS samples and found to be higher
in formula-fed infants than in breastfed infants.8 Extensive
work using high-resolution mass spectrometry has also
demonstrated striking differences between the DBS lipido-
mic profiles of breastfed and formula-fed infants at 3
months of age (N¼ 241); differences were evident across
all main lipid classes, with mixed-fed infants showing
intermediate profiles.15 Breastfed infants had higher levels
of cholesterol esters, lower total phosphatidylcholines (PC)
and specific differences in many individual PCs and sphin-
gomyelin lipid species.
Age of weaning
Age of weaning (introduction of semi-solid or solid foods)
was inversely related to infancy weight and length, but
these associations are likely to be due to reverse causal-
ity.16 Consistent with evidence synthesized across other
studies, these findings suggest that infants who grow faster
are more likely to be weaned earlier than other infants, but
that in turn age at weaning has neutral effects on infant
growth.
Feeding practice and infant behaviour
Maternally-rated infancy temperament differed between
breast/mixed-fed and formula-fed infants at 3 months of
age.17 Breastfed and mixed-fed infants were rated as hav-
ing more challenging temperaments, with lower soothabil-
ity, greater distress and less positive response to
stimulation. These results may allow better understanding
and expectation of normal infant temperament and this
knowledge, with appropriate support, could be used to
promote successful breastfeeding.
Regulation of postnatal growth
Hormones
We demonstrated that infant DBS IGF-1 levels at age 3
months predicted subsequent faster linear growth and
lesser gains in adiposity, up to the age of 12–18 months.8 It
is likely that other hormones mediate the faster gains in
adiposity seen in contemporary milk formula-fed infants,
and we are currently investigating several hormones,
including leptin, which are positively associated with
weight and adiposity in infancy. Preliminary work has also
suggested that several specific lipid species in the infancy
lipidome are related to 3- and 12-month weight.15
Genes
An individual-level meta-analysis of CBGS and three other
European birth cohorts showed that adult obesity-risk
alleles were not associated with birth size, but were posi-
tively associated with body size at 1 year, with strengthen-
ing correlations seen across the first 5 years of life.18 These
alleles were not only associated with fat mass, as seen in
older populations, but had a symmetrical influence on
both body size and body composition (lean and fat mass).
Of note, these alleles showed less influence on infants born
with low or high birthweights than on those of average
birthweight.











DNA methylation patterns have been measured in selected
sub-groups—infants of mothers with gestational diabetes
and infants demonstrating rapid postnatal weight gain
over the first year of life—and compared with a group of
control infants. We found multiple differentially methy-
lated sites, including at or near genes with known rele-
vance to growth and diabetes, and several methylation
differences that were common to infants of mothers with
gestational diabetes and infants who showed rapid infancy
weight gain.19 This work suggests that similar epigenetic
changes may occur after different in utero exposures, and
may possibly contribute to the same long-term phenotype,
for example with increased risk of obesity and type 2
diabetes.
Male reproductive development
CBGS is one of the largest cohort studies with repeated
measurements of infancy penile length, testicular descent
and anogenital distance (AGD) (a marker of androgen
exposure). The study has generated normative data for
infancy anogenital distance, for both boys and girls.20
AGD increased from birth up to age 12 months in a sexu-
ally-dimorphic pattern, and was positively correlated with
penile length at birth. These normative data will be useful
as markers of androgen action in further studies investigat-
ing environmental effects on genital development. CBGS
data also showed a higher incidence of congenital cryp-
torchidism than reported in earlier UK studies.21 We are
currently investigating a possible role for EDCs in male
reproductive disorders, exploring data on maternal first-
trimester serum phthalate and phenol levels. We are also
exploring how EDCs affect maternal metabolism during
pregnancy.
What are the main strengths and
weaknesses?
Particular strengths of the CBGS cohort design include the
rich collection of biological data and samples, including on
maternal metabolism during pregnancy, environmental
and dietary exposures and infant and breast milk samples.
Information was obtained on both parents, and involve-
ment of fathers meant that it was possible to analyse DNA
trios, from mother, father and infant.
Multiple collaborations have enabled diverse laboratory
analyses, including state-of-the-art mass spectrometry for
novel metabolite and lipid profiling in infancy. As reflected
by a dearth of reported data on hormone and metabolite
levels between birth and mid-childhood, a major strength
of CBGS is the collection of biological samples (largely by
DBS sampling) from 3 months of age, as well as the large
number of breast milk samples and DNA trios.
Limitations of CBGS include its single-site design and
prolonged recruitment over an 8-year period. From birth to
age 2 years, there was a 34% attrition rate which is compa-
rable to other UK longitudinal cohorts. There are advan-
tages and disadvantages of its South Cambridgeshire setting.
The cohort is almost exclusively White Caucasian, which
reduces confounding but also limits generalizability to other
settings and populations. Additionally, the cohort has high
rates of exclusive breastfeeding, compared with the whole
of the UK. However, this improves the power for differences
between breastfed and formula-fed infants to be observed.
A limitation of the body composition assessments is the
absence of lean mass estimation, other than by extrapola-
tion from skinfold thicknesses. With increasing evidence
supporting the importance of the first few months of life as
a critical period for long-term outcomes, rather than just
the first year of life,22–24 it would have been beneficial to
include more frequent assessments, particularly in very
early infancy.
Can I get hold of the data? Where can I find
out more?
Anonymized data are available to other investigators
through collaborative agreements, and the CBGS co-inves-
tigators welcome formal or informal proposals and will
consider these at their bimonthly meetings. Please contact
Dr Carlo Acerini [cla22@cam.ac.uk].
CBGS in a nutshell
• The CBGS is a prospective, observational pregnancy and
birth cohort, primarily investigating antenatal and post-
natal determinants of infancy growth and development.
• A total of 2229 pregnant women were recruited at
approximately 12 weeks of gestation from one tertiary
hospital in Cambridge, UK; 1658 newborns entered the
infancy follow-up, born between 2001 and 2009.
• Detailed information collected during pregnancy
included a first-trimester blood sample, oral glucose tol-
erance test and questionnaire data for demographics,
medical history and environmental and dietary
exposures.
• Infants were seen newborn and at 3, 12, 18 and 24
months of age, with longitudinal anthropometric meas-
ures, dried blood spot samples and questionnaire data.
Breast milk and genetic data are also available.
• Any researcher interested in collaborating with the CBGS
should contact Dr Carlo Acerini [cla22@cam.ac.uk].
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